F19.93
Other psychoactive substance use, unspecified with withdrawal
Clinical Classification Guidelines
Excludes Type 1
- other psychoactive substance use, unspecified with intoxication (F19.92-)
Medical Intelligence & Overview
ICD-10 code F19.93 refers to a condition involving the use of psychoactive substances, where the specific substance has not been clearly identified, and the individual is experiencing withdrawal symptoms. Psychoactive substances include a wide range of drugs that affect the brain’s functioning, often impacting mood, consciousness, and behavior. This diagnosis highlights the complexity of substance use disorders, especially when the exact substance involved is unknown or unspecified, and emphasizes the importance of managing withdrawal symptoms safely.
Causes & Symptoms
Clinical Causes: Use of various psychoactive substances such as alcohol, opioids, stimulants, sedatives, or hallucinogens Repeated or excessive consumption leading to physical dependence Unintentional or accidental intake of a psychoactive compound Attempting to self-medicate mental health issues with substances Lack of awareness or difficulty in identifying specific substance used
Key Symptoms: Physical withdrawal signs such as sweating, tremors, nausea, or vomiting Psychological symptoms including anxiety, irritability, or agitation Insomnia or disturbed sleep patterns Changes in mood such as depression or euphoria Cravings for the substance Tremors or seizures in severe cases Dilated pupils or other altered physical sensations
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves clinical evaluation, including a detailed interview about substance use history, review of symptoms, and exclusion of other medical or psychiatric conditions. Laboratory tests such as toxicology screening may be used to detect the presence of psychoactive substances. Healthcare providers also assess the severity of withdrawal symptoms to guide appropriate treatment planning.
Treatment Protocols: Treatment approaches aim to manage withdrawal symptoms and address underlying substance use disorder. Common interventions include:
Clinical Advice & FAQs
Billing Guidance
Is F19.93 a billable ICD-10 code?
Yes, F19.93 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.93?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with withdrawal and any associated comorbidities for accurate reporting.
Cite this Clinical Reference